ST-246

tecovirimat · SIGA Technologies

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ST-246, covering 2010-05-07 to 2010-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246 [Phase 2]